The increase was driven by similar jumps in the company's reconstructive, MedSurg, neurotechnology and spine business lines. The company also reported a net earnings increase of 14 percent to $350 million.
Acquisitions in the spine and neurotechnology businesses drove a 12.4 percent net sales increase, while increased unit volume and changes in product mix also contributed to the business line's success.
The company's knee and hip business lines also reported a net sales increase of 3.3 percent and 5.1 percent, respectively. During the first quarter, the company incurred $17 million in acquisition- and integration-related charges for Neurovascular, Orthovita, Memometal and Concetric acquisitions.
More articles on Orthopedic Devices:
DePuy Spine Launches Pedicular Screw System for Spinal Fusions
Medtronic Launches Electronic Power Instruments for Spinal Surgery
17 Spine Devices Receive FDA 510(k) Clearance in March
Stryker Q1 Sales Soar 7.2%, Spine Sales Driven by AcquisitionsWritten by Laura Miller | April 18, 2012
Stryker reported first quarter net sales at $2.2 billion, a 7.2 percent increase over the first period of 2011.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.